R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

AI has begun to influence early-stage antibiotic discovery by identifying novel antibacterial compounds that are difficult to uncover traditionally.

R&D

As Parkinson’s Awareness Month comes to a close, the urgency to challenge the status quo has never been greater.

R&D

pharmaphorum spoke with three female experts from Thermo Fisher Scientific about women in STEM today and tomorrow.

R&D

Clinical trial expansion comes with complexity and increased risk, as each country has distinct regulatory requirements and contractual expectations.

R&D

Oligo therapies are emerging as promising therapeutics with the potential to address previously untreatable conditions.

R&D

pharmaphorum spoke with DiaMedica’s CEO, Rick Pauls, about the company's efforts in preeclampsia, early-onset preeclampsia, and ischaemic stroke.